Clinical Trial Update: Fatty Liver Study in Patients With Type II Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 fatty liver study in patients with type 2 diabetes was terminated, and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Type II Diabetes, Nonalcoholic Fatty Liver | Phase 4 | Status: TERMINATED | Results posted: 2018-07-31